The Spring Course: Best of DDW 2017
333 East 47th Street (near First Avenue)
New York, NY 10017
Information for Exhibitors
Click Here for Information on Exhibiting at The Spring Course: Best of DDW 2017
Click Here for Parking Information
Practicing gastroenterologists, gastrointestinal endoscopists and surgeons, GI fellows, and GI nurses and associates
Agenda and Faculty
Click Here for the Agenda and Faculty
The expanded program includes physician-focused sessions on Friday afternoon at no additional charge. Registration rates remain the same as last year and each day's content is independent of the other.
By May 12
After May 12
|Day 1 Only
By May 12
After May 12
|Day Two Only
By May 12
After May 12
For secure online registration by credit card, click on the Register Now! button at the top or bottom of this page.
View or Download the Manual Registration Form (for check payments or registration by fax).
Contact email@example.com for assistance or call 646-218-0650.
The Spring Course is devoted to a review of the most compelling topics in gastroenterology, endoscopy, and liver disease as presented during Digestive Disease Week®, May 6-9, 2017. At this event, the most significant data from national and international research efforts is presented, affording attendees a first look at critically important information on new drugs, the etiology and pathophysiology of disease states, the epidemiology of diseases, the medical, surgical and endoscopic treatment of disease, and the social impact of disease states in the fields of gastroenterology, hepatology, and GI surgery.
The program includes a video forum of new endoscopic techniques as well as a summary of the major topics presented at the most important academic forum in gastroenterology, making for an invaluable educational experience for those who were unable to attend Digestive Disease Week® and an excellent summary review for those who did.
- Discuss the spectrum of commonly seen esophageal motility disorders, and outline both current treatment options and the effectiveness of these therapies.
- Identify novel therapies in the management of gastroesophageal reflux disease and Barrett’s Esophagus, including medical, endoscopic and surgical approaches.
- Identify the presence and treatment of common disorders of the small bowel including celiac disease and small intestinal bacterial overgrowth, and review the current role of imaging in small bowel disease.
- Evaluate the commonly seen types of colon polyps, recognize the progression of such polyps to malignancy, and review data on the efficacy and safety of techniques for removal of colorectal polyps.
- Identify appropriate methods to assess mucosal damage and disease status in patients with inflammatory bowel disease, and then discuss the application of these techniques in the evaluation of healing and successful treatment.
- Identify novel medical and endoscopic approaches in managing obesity, and evaluate the effectiveness of these techniques.
- Evaluate current advances in both diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) including management and treatment of biliary stones, cholangitis, strictures, malignancies, and prevention of pancreatitis.
- Review state-of-the-art use of endoscopic ultrasound in the diagnosis of and therapy for disorders of the gastrointestinal tract, including pancreatic cysts, solid masses, lymph nodes, injection therapies, and drainage of collections.
- Examine the effectiveness and safety of new treatments for hepatitis B, hepatitis C, and non-alcoholic steatohepatitis (NASH). Discuss the role of imaging in diagnosis and surveillance of hepatocellular carcinoma in patients with chronic liver disease.
- Examine and discuss novel endoscopic therapies in comparison to traditional medical and interventional treatments.
- Demonstrate tools and skills necessary to accurately identify and effectively treat complications of gastrointestinal endoscopy.
- Recognize the diagnostic and therapeutic capabilities of interventional endoscopy. Identify appropriate methods to detect and assess dysplasia and early mucosal cancers of the gastrointestinal tract, and evaluate the various endoscopic and surgical treatment modalities for these early malignancies.
It is the policy of the Icahn School of Medicine at Mount Sinai Continuing Medical Education Office that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity and have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Icahn School of Medicine at Mount Sinai and the New York Society for Gastrointestinal Endoscopy. The Icahn School of Medicine at Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
The Icahn School of Medicine at Mount Sinai Continuing Medical Education Office designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Nursing Accreditation Statement
This continuing nursing education activity has been approved by the Northeast Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation for 6.0 hours. Maine, New Hampshire, New York, Rhode Island, Vermont Nurses Associations are members of the Northeast Multi-State Division of the American Nurses Association.
This educational activity has been approved by the Certification Board for Sterile Processing and Distribution, Inc. (CBSPD) for continuing education credit toward maintenance of certification for 5.5 hours.